Nanoliposomal oxaliplatin ameliorates chemotherapy-induced neuropathy

Alaei, M; Moetamani-Ahmadi, M; Mahaki, H; Fiuji, H; Maftooh, M; Hassanian, SM; Khazaei, M; Shahri, AP; Ferns, GA; Frozanfar, F; Tanzadehpanah, H; Avan, A

Tanzadehpanah, H; Avan, A (通讯作者),Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Iran.;Tanzadehpanah, H; Avan, A (通讯作者),Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Iran.;Avan, A (通讯作者),Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Australia.

NEUROSCIENCE LETTERS, 2023; 812 ():

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is an important adverse effect of treatment with oxaliplatin (OXA). We have developed PEGylated nano......

Full Text Link